Table 1. Characteristics of studies included in the meta-analysis.
No. | Study | Year | Ethnicity | Cancer type | Source of controll† | Genotyping method | HWE control | Case |
Control |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TT | CT | CC | TT | CT | CC | ||||||||||
1 | Min KT [24] | 2011 | Asian | colorectral | PB | PCR-RFLP | 0.633 | 125 | 201 | 120 | 148 | 254 | 100 | ||
2 | Zhang M [25] | 2011 | Asian | breast | PB | PCR-RFLP | 0.904 | 148 | 89 | 11 | 133 | 93 | 17 | ||
3 | Zhan JF [26] | 2011 | Asian | colorectral | HB | PCR-RFLP | 0.849 | 56 | 128 | 68 | 163 | 267 | 113 | ||
4 | Zhou B [27] | 2011 | Asian | squamous cell cancer | HB | PCR-RFLP | 0.077 | 57 | 123 | 46 | 82 | 169 | 58 | ||
5 | Hong YS [14] | 2011 | Asian | lung | HB | TaqMan | 0.163 | 96 | 224 | 86 | 134 | 198 | 96 | ||
6 | Zhang XW [28] | 2011 | Asian | hepatocellular | PB | PIRA-PCR | 0.52 | 277 | 449 | 208 | 477 | 817 | 328 | ||
7 | Zhu LJ [29] | 2011 | Asian | colorectral | NC | TaqMan | 0.79 | 130 | 303 | 140 | 172 | 295 | 121 | ||
8 | Chen H [30] | 2011 | Asian | colorectral | HB | PCR-LDR | 0.788 | 35 | 64 | 27 | 107 | 206 | 94 | ||
9 | Okubo M [31] | 2010 | Asian | gastric | HB | PCR-RFLP | 0.51 | 166 | 281 | 105 | 223 | 350 | 124 | ||
10 | Dou T [17] | 2010 | Asian | glioma | HB | PCR-LDR | 0.119 | 189 | 343 | 111 | 208 | 305 | 143 | ||
11 | Wang K [32] | 2010 | Asian | esophageal | NC | SNaPshot | 0.6 | 48 | 262 | 148 | 111 | 250 | 128 | ||
12 | Peng S [18] | 2010 | Asian | gastric | HB | PCR-RFLP | 0.936 | 43 | 94 | 76 | 50 | 107 | 56 | ||
13 | Qi P [33] | 2010 | Asian | hepatocellcular | NC | PCR-LDR | 0.793 | 159 | 286 | 115 | 102 | 197 | 92 | ||
14 | Tian T [15] | 2009 | Asian | lung | PB | PCR-RFLP | 0.7 | 293 | 512 | 253 | 307 | 519 | 209 | ||
15 | Hu Z [34] | 2009 | Asian | breast | PB | PCR-RFLP | 0.207 | 287 | 483 | 239 | 358 | 517 | 218 | ||
16 | Li XD [22] | 2010 | Asian | hepatocellcular | HB | PCR-RFLP | 0.402 | 82 | 150 | 78 | 78 | 102 | 42 | ||
17 | Kim JM [35] | 2010 | Asian | lung | PB | PCR-MCS | 0.6 | 162 | 305 | 187 | 185 | 300 | 155 | ||
18 | Jedlinski DJ [36] | 2011 | Caucasion | breast | PB | PCR-RFLP | 0.83 | 33 | 86 | 68 | 31 | 82 | 58 | ||
19 | Akkiz H [23] | 2011 | Caucasion | hepatocellular | HB | PCR-RFLP | 0.492 | 22 | 86 | 77 | 40 | 87 | 58 | ||
20 | Mittal RD [37] | 2011 | Caucasion | bladder | HB | PCR-RFLP | 0.003 | 5 | 131 | 76 | 14 | 127 | 109 | ||
21 | George GP [38] | 2011 | Caucasion | prostate | PB | PCR-RFLP | 0.002 | 3 | 101 | 55 | 10 | 114 | 106 | ||
22 | Liu Z [20] | 2010 | Caucasion | head and neck | HB | PCR-RFLP | 0.737 | 194 | 565 | 350 | 202 | 545 | 383 | ||
23 | Srivastava K [19] | 2010 | Caucasion | gallbladder | PB | PCR-RFLP | 0.068 | 16 | 95 | 119 | 19 | 75 | 136 | ||
24 | Catucci I [39] | 2010 | Caucasion | breast | NC | TaqMan | 0.708 | 244 | 842 | 766 | 377 | 1246 | 1116 | ||
25 | Hoffman AE [16] | 2009 | Caucasion | breast | NC | Sequenom MassARRAY | 0.583 | 36 | 209 | 181 | 71 | 229 | 166 | ||
26 | Ye Y [21] | 2008 | Caucasion | esophageal | HB | SNPlex assay | 0.477 | 83 | 141 | 83 | 59 | 172 | 107 | ||
27 | Vinci S [40] | 2011 | Caucasion | lung | NC | HRMA | 0.267 | 12 | 54 | 35 | 10 | 61 | 58 |
†, HB:hospital-based; PB:population-based; NC:not clear.